Bill introduced
Gilbert Ray Cisneros, Jr. bought K
Lobbying filed by AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC
Lobbying filed by AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC
| Registrant | Client | Amount | Filed | Period | Issues |
|---|---|---|---|---|---|
| AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC. | AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC | $263.0M | Jul 21, 2025 | 2025Q2 | HCRTAXTOB |
| AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC. | AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC | $198.0M | Apr 21, 2025 | 2025Q1 | HCRTAXTOB |
Congress members who traded stocks in companies connected to lobbying on this bill, within 90 days of its introduction date.
| Member | Party | Ticker | Company | Trade | Date | Amount | Timing | Lobbying Client | Conflict |
|---|---|---|---|---|---|---|---|---|---|
| Gilbert Ray Cisneros, Jr. | D | K | K | Buy | Jan 24, 2025 | $1,001 - $15,000 | 21d after | AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC | 1% |
1 trade by 1 member of Congress in companies connected to lobbying on HR 150. The average conflict score is 1%.
CapitolExposed identifies the "bill-lobbying-trade pipeline" by: (1) finding lobbying filings (LD-2) that specifically mention this bill, (2) matching lobbying clients to publicly traded companies, and (3) finding stock trades by members of Congress in those companies within 90 days of the bill's introduction date. Trades made before the bill was introduced are highlighted in red, as they may indicate advance knowledge. This analysis surfaces correlations worthy of scrutiny; it does not prove wrongdoing.